Abstract
e11578 Background: While only 20% of all breast cancer is HER2+, it represents a disproportionate majority of breast cancer brain metastases, and up to half of these patients will die of CNS diseas...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have